Initially theorized in 2004 by Dr. Ethan Russo, Clinical Endo-Cannabinoid Deficiency is thought to be responsible for migraines, fibromyalgia, inflammatory bowel disease and other related conditions that affect nearly 20 percent of Americans daily. In January of this year, a unique partnership between … Read More
The post Cannalogix-Anantlife Partnership Offers Unique DNA Test For Cannabis Side Effects: An Exclusive … appeared first on Dagga Magazine.